Abstract
The Covid-19 first occurs in Wuhan, China in December 2019. After that the virus spread all around the world and at the time of writing this paper the total number of confirmed cases are above 4 million with over 297000 deaths. Machine learning algorithms built on radiography images can be used as a decision support mechanism to aid radiologists to speed up the diagnostic process. The aim of this work is twofold. First, a quantitative analysis where we evaluate 12 off-the-shelf convolutional neural networks (CNNs) and proposed a simple CNN architecture with less parameters and computational power that can perform as good as Xception and DenseNet architectures if trained on small dataset of chest X-ray images. Secondly, a qualitative investigation to inspect the decisions made by CNNs using a technique known as class activation maps (CAM). Using CAMs, one can map the activations contributed most to the decision of CNNs back to the original image to visualize the most discriminating regions in the input image. Chest X-ray images used in this work are coming from multiple sources which comprises of 154 confirmed COVID-19 images and over 5000 X-rays of normal, bacterial and other viral (non-COVID-19) infections. We conclude that CNN decisions should not be taken into consideration until radiologist/clinicians can visually inspect the region(s) of the input image used by CNNs that lead to its prediction. This work also reports the necessity of segmenting the region of interest (ROI) to prevent CNNs building their decision from features outside ROI.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data and trained Models are available upon request.